The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 1 , Page 8 , July 2009

Uric acid levels and outcomes from coronary artery bypass grafting: Is it the chicken or the egg?

  • Harold L. Lazar, MD

      Affiliations

    • Corresponding Author InformationAddress for reprints: Harold L. Lazar, MD, Boston Medical Center, Cardiothoracic Surgery, 88 E. Newton St, Suite B 404, Boston, MA 02118.

Received 21 January 2009 ,Revised 20 February 2009 ,Accepted 7 March 2009.

References 

  1. Hills GS, Cuthbertson BH, Gibson PH, NcNeilly JD, Maclennan GS, Jeffrey RR, et al. Uric acid levels and outcomes from coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2009;138:200–205
  2. Bickel C, Rupprecht HJ, Blankenberg S, Rippin G, Hafner G, Daunhauer A, et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol. 2002;89:12–17
  3. Sisto T, Paajanen H, Metsa-Ketela T, Harmoinen A, Nordback I, Tarkka M. Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass grafting. Ann Thorac Surg. 1995;59:1519–1523
  4. Anderson RE, Klerdal K, Ivert T. Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery?. Eur Heart J. 2005;26:1513–1518
  5. Rathman W, Funkhouser E, Dyer AR, Roseman JM. Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults; the CARDIA study. Ann Epidemiol. 1998;8:250–261

PII: S0022-5223(09)00496-6

doi: 10.1016/j.jtcvs.2009.03.040

The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 1 , Page 8 , July 2009

Article Tools